PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
14-Nov-2022 PAION AG’S PARTNER TTY BIOPHARM RECEIVES MARKET APPROVAL FOR REMIMAZOLAM IN PROCEDURAL SEDATION IN TAIWAN PAION AG
14-Nov-2022 EVERSANA® Names Experienced Life Sciences Leader Sy Pretorius Chief Operating Officer & President, Outsourced Solutions to Propel Next-Generation Commercialization Services Worldwide EVERSANA®
14-Nov-2022 EpiEndo Commences Phase 2a Trial for EP395 in COPD Patients EpiEndo
14-Nov-2022 Luforbec® 200/6 (beclometasone 200mcg / formoterol 6mcg) a certified carbon neutral inhaler is launched in the UK for the treatment of adult asthma Lupin Healthcare UK
14-Nov-2022 EpiEndo Commences Phase 2a Trial for EP395 in COPD Patients B3C newswire
14-Nov-2022 InaVac gets emergency approval from BPOM Airlangga University
14-Nov-2022 Biotest AG: Biotest reports sales of Euro 361 million in the first nine months of 2022 Biotest AG
14-Nov-2022 Biotest AG: Biotest receives approval for new intravenous immunoglobulin Yimmugo® (IgG Next Generation) Biotest AG
14-Nov-2022 M1 Kliniken AG announces figures for Q3 2022: Group continues the expansion course with development of a new country market M1 Kliniken AG
14-Nov-2022 HAEMATO AG: publishes figures for the 3rd quarter 2022 HAEMATO AG
14-Nov-2022 MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab in Early Alzheimer’s Disease MorphoSys AG
14-Nov-2022 Ad hoc: MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab in Early Alzheimer’s Disease MorphoSys AG
14-Nov-2022 Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements Relief Therapeutics Holding SA
14-Nov-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Report Q3 2022 Financial Results and Operational Progress on November 22, 2022 Vivoryon Therapeutics N.V.
11-Nov-2022 Orgenesis achieves revenue of USD 8.0 million for the third quarter of 2022 Orgenesis Inc
11-Nov-2022 Aptar Pharma Announces Collaboration with TFF Pharmaceuticals to Develop Intranasal Delivery of Dry Powder Vaccines and Therapeutics Aptar Pharma
11-Nov-2022 CureVac Presents Preliminary Data from Phase 1 Study Expansion of Oncology Candidate CV8102 CureVac
11-Nov-2022 Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy Novotech Health Holdings Pte Ltd
11-Nov-2022 Weekly Pharma & Life Science News Round-Up: 7th November – 11th November PharmiWeb.Jobs
11-Nov-2022 Spotlight on Healthcare Collaboration and Innovation at Asia Summit on Global Health and HK International Medical and Healthcare Fair HKTDC